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INTRODUCTION 
Tablet is the most widely used dosage form because of 
its convenience in terms of self-administration, 
compactness and ease in manufacturing. However, 
geriatric and paediatric patients experience difficulty in 
swallowing conventional tablets, which lead to poor 
patient compliance. To overcome these problems, 
scientists developed innovative drug delivery systems 
known as “Oral Disintegrating Tablets” (ODT). These 
are novel type of tablets that 
disintegrate/disperse/dissolve in saliva
1, 2, 3
. The target 
populations for these oral disintegrating dosage forms 
have generally been paediatric, geriatric and bedridden 
or developmentally disabled patients who have 
dysphagia.  Patients with persistent nausea, sudden 
episodes of allergic attacks or coughing, who are 
travelling, or who have little or no access to water are 
also good candidates for oral disintegrable tablets
4
. The 
benefits in terms of patient compliance, rapid onset of 
action, increased bioavailability and good stability make 
these tablets popular as a dosage form of choice in the 
current market. Some drugs are absorbed from the 
mouth, pharynx and oesophagus when the saliva passes 
down into the stomach, in such cases bioavailability of 
drug is significantly greater than those observed from 
conventional tablet dosage form
5, 6
. 
ODTs with good taste and flavor increase the 
acceptability of bitter drugs by various groups of 
population. Various techniques available for 
formulating ODTs include freeze drying, sublimation, 
spray drying, tablet moulding, and melt granulation
7 
etc. 
Despite the different mechanisms involved in these 
techniques, the aim is to provide the tablet that quickly 
disintegrate or dissolve upon contact with saliva and 
also to provide a good mouth feel. 
MATERIALS AND METHOD: 
Materials: 
Donepezil Hydrochloride was obtained as gift sample 
from RA Chem Pharma Ltd, Hyderabad. Karaya gum, 
agar and glycine obtained from Yarrow Chem. Products 
and Kyron T-314 from Corel Pharma Chem Ltd. 
 
 
*Corresponding Author: 
Prof. Dr. P.K. Lakshmi, 
HOD, Department of Pharmaceutics, 
G.Pulla Reddy College of Pharmacy, Hyderabad. 
E-mail:drlakshmisuresh@gmail.com 
Mobile: +91-9000044452.
  
ABSTRACT 
The objective of the study was to prepare and evaluate orodispersible tablets of Donepezil Hydrochloride (DPH) using natural 
modified polysaccharides such as modified karaya gum and modified agar with glycine and mannitol. The prepared 
formulations were compared with Kyron T-314, a super disintegrant, spray dried lactose, a diluent for improvement in DT and 
other ODT parameters. FTIR studies revealed no interaction between DPH and excipients. Precompression parameters for all 
formulations were found to be satisfactory. The oral dispersible tablets formulated using modified agar with glycine showed 
better disintegration time compared to modified karaya gum formulations. Different concentrations of mannitol and glycine 
were used in the formulation to study the improvement in the DT. The glycine formulations with modified agar gave better 
ODT parameters than modified karaya gum with mannitol and glycine formulations. The optimized formulations of modified 
agar with glycine in different concentrations were prepared with spray dried lactose as diluent and compared with formulations 
of Kyron T-314 as superdisintegrant with spray dried lactose as diluent. The results of lactose and spray dried lactose as 
diluents in these formulations did not show any significant difference in ODT evaluation parameters. The formulations were 
optimized using ODT parameters such as disintegration time, wetting time, water absorption ratio and other physicochemical 
evaluation parameters.  The accelerated stability studies of optimized formulation did not show significant changes compared to 
initial physicochemical evaluation parameters. To conclude, modified polysaccharides with glycine can be used as 
superdisintegrant, which may be a cost effective alternative in comparison to synthetic superdisintegrant like Kyron T-314. 
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Methods: 
Preparation and evaluation of modified karaya gum 
and modified agar: Modified karaya gum was 
prepared from tears of karaya gum, were pulverized and 
then passed through sieve No.100. Ten grams of the 
powdered gum was taken in a china dish and subjected 
to heating at 120C for 2 hours in a hot air oven, and for 
modified agar the powder was mixed with distilled 
water and stirred, then kept for swelling. It was kept for 
three days for drying and ground to pass through sieve 
No.100. Both the modified gums were evaluated for 
viscosity (Brookefield viscometer LV DV-II+Pro) and 
swelling index. 
Preparation and evaluation of donepezil 
hydrochloride oro-dispersible tablets: 
Formulation of orodispersible tablets of DPH with 
glycine & mannitol as excipient: 
5mg tablets of total weight 50mg containing 40-60% of 
glycine and mannitol were prepared but all were found 
to show poor flow property. 
Formulation of orodispersible tablets of DPH with 
modified karaya gum and modified agar
 
Table 1: Formulation of ODT of DPH containing modified gums 
Formulation Drug(mg) Modified karaya gum (mg) Modified agar (mg) Lactose (mg) 
DPHMK1 5 2.5 - 42 
DPHMK2 5 3.75 - 40.75 
DPHMK3 5 5 - 39.5 
DPHMA1 5 - 2.5 42 
DPHMA2 5 - 3.75 40.75 
DPHMA3 5 - 5 39.5 
Note: All the above formulations of tablets 2% PVPK-30 was added as binder, 0.25mg of Mg.stearate and talc. Total weight of 
tablet was 50 mg. 
Uniformly mixed blend was compressed into tablets 
containing 5mg drug using 6mm flat face surface 
punches on a Rimek-1 rotary tablet machine by direct 
compression method. 
Evaluation of oral disintegrable tablets: 
Wetting time: 
Five circular tissue papers of 10-cm diameter were 
placed in a petri dish with a 10-cm diameter. 10 ml of 
water at 37
º
C±0.5
º
C containing eosin, a water-soluble 
dye, was added to the petri dish. A tablet was carefully 
placed on the surface of tissue paper. The time required 
for water to reach the upper surface of the tablets was 
noted as the wetting time. Six tablets from each 
formulation batch were tested randomly and the average 
reading noted.
 
Water absorption ratio: 
A piece of tissue paper folded twice was placed in a 
small Petri dish containing 6 ml of water. A tablet was 
put on the paper and the time required for complete 
wetting was measured. The wet tablet was weighed. 
Water absorption ratio R, was determined using 
following equation 
R = Wa – W b /Wb ×100……………….Eq. no.3.8 
 Where Wa = weight of tablet after absorption 
             Wb = weight of tablet before absorption 
Disintegration time: 
Disintegration time was measured using a modified 
disintegration method. For this purpose, a Petri dish was 
filled with 10 ml of water at 37
º 
C±0.5
º
C. The tablet was 
carefully put in the centre of the petridish and the time 
for the tablet to completely disintegrate into fine 
particles was noted. 
Assay:  
20 tablets were randomly selected and average weight 
was calculated. Tablets were powdered in a glass 
mortar. Powder equivalent to 5 mg was weighed and 
dissolved in 100 ml of 0.1N HCl ml volumetric flask. 
This dispersion was filtered and 1.2 ml of the above 
solutions were taken and diluted to 10 ml with 0.1N 
HCl. The absorbances of this solution were determined 
at 230 nm against the blank. The percentage assay was 
calculated from the standard curve. 
In-vitro release:  
In-vitro drug release of oral disintegrable tablets was 
determined using USP dissolution apparatus II (Paddle 
type) (Electrolab TDT-08L). The dissolution test was 
performed using 900 ml 0.1N HCL at 37
º
C ± 0.5
º
C. The 
speed of rotation of paddle was set at 50 rpm. 5 ml 
samples were withdrawn at time points of 1, 3, 5, 10, 
15, 20 min and same volume was replaced with fresh 
media. Absorbance of solution was checked by UV 
spectrophotometer (ELICO- 164 double beam 
spectrophotometer) at a wavelength of 230 nm and drug 
release was determined from standard curve. 
Formulation of orodispersible tablets using modified 
polysaccharides with glycine/mannitol
8 
Modified karaya gum/Modified agar was mixed with 
glycine/mannitolin a glass pestle mortar and triturated 
for 20 min.  The ground mixture was passed through 
sieve No.22 to get the modified polysaccharides with 
glycine or mannitol. 
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Table 2: Formulation of ODT of DPH containing modified gums with glycine 
Formulation Drug (mg) 
Modified 
karaya gum 
(10%) 
Glycine Mannitol Lactose (mg) Formulation 
Drug 
(mg) 
Modified 
agar 
(10%) 
Glycine Mannitol Lactose (mg) 
DPHMKM1 5 5 20mg - 19.5 DPHMAM1 5 5 20mg - 19.5 
DPHMKM2 5 5 25mg - 14.5 DPHMAM2 5 5 25mg - 14.5 
DPHMKM3 5 5 30mg - 9.5 DPHMAM3 5 5 30mg - 9.5 
DPHMKG1 5 5 - 20mg 19.5 DPHMAG1 5 5 - 20mg 19.5 
DPHMKG2 5 5 - 25mg 14.5 DPHMAG2 5 5 - 25mg 14.5 
DPHMKG3 5 5 - 30mg 9.5 DPHMAG3 5 5 - 30mg 9.5 
Note: All the above formulations of tablets containing different concentrations and it contain 0.25mg of Mg.stearate and talc. Total weight of tablet is 50 mg. 
 
From these preparations the optimized formulations were formulated with spray dried lactose and with various proportions of Kyron K-314 were prepared 
Table 3: Formulation of optimized formulations with spray dried lactose 
 
 
 
 
 
 
 
Note: All the above formulations of tablets containing different concentrations of 0.25mg of Mg. stearate and talc. Total weight of tablet is 50 mg. 
Comparative evaluations of optimized modified agar formulations were compared with optimized Kyron-T314 formulations. 
Accelerated stability studies: 
The optimized formulation was subjected to stability studies at 40
º
C±2
º
C/75%±2%RH for period of one month. Each tablet was individually wrapped in aluminum foil and packed in 
ambered colored bottle and put at above specified condition in a heating humidity chamber for one month. The tablets were analyzed for the hardness, disintegration time, and drug 
content and in-vitro drug release. 
 
 
 
 
FORMULATION Drug(mg) MKG(mg) MAG(mg) 
Kyron 
K-314 
Spray dried 
Lactose(mg) 
DPHMKG2S 5 30 - - 14.5 
DPHMKG3S 5 35 - - 9.5 
DPHMAG2S 5 - 30 - 14.5 
DPHMAG3S 5 - 35 - 9.5 
DPHK1S 5 - - 0.4 44.01 
DPHK2S 5 - - 0.5 44 
DPHK3S 5 - - 0.6 43.9 
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RESULTS AND DISCUSSION: 
Evaluation of Orodispersible tablets of DPH using modified karaya gum and modified agar: 
Table 4: Post compression parameters of orodispersible tablets of DPH using modified karaya gum and modified agar 
Formulation 
Weight 
variation 
(mg) 
Hardness 
(kg/cm2) 
Thickness 
(mm) 
Friability 
(%) 
Disintegration 
time (sec) 
Wetting time 
(sec) 
Water 
absorption 
ratio 
Content 
uniformity Assay Q20 
(%) 
DPHMA1 51±1.05 2.5 2.71±0.02 0.22±0.18 30±1.96 35±1.12 132±1.42 99.24±0.58 99.22±0.51 95.67±0.50 
DPHMA2 50±0.89 2.5 2.69±0.01 0.25±0.24 25±1.21 27±1.32 135±1.46 99.85±0.86 98.82±0.65 96.90±1.47 
DPHMA3 49±0.98 3 2.72±0.04 0.22±0.15 20±1.90 25±1.76 137±1.38 99.62±0.69 99.64±0.54 94.38±1.28 
DPHMK1 50±0.98 2 2.71±0.02 0.28±0.21 50±1.24 55±1.57 139±1.26 99.45±0.68 99.02±0.59 94.27±1.26 
DPHMK2 50±1.86 2.5 2.69±0.04 0.27±0.16 35±1.52 40±1.43 113±1.81 99.62±0.99 99.26±0.78 95.53±1.64 
DPHMK3 52±0.86 3 2.72±0.02 0.27±0.16 25±1.23 30±1.65 123±1.43 99.65±0.79 99.36±0.89 96.78±1.71 
From the above results modified agar preparation (DPHMA3) was found to show better DT compared with modified karaya gum preparations but the %release was less. 
Evaluation of orodispersible tablets of DPH using modified karaya gum with glycine and mannitol 
Table 5: Post compression parameters of orodispersible tablets of DPH using modified karaya gum with glycine and mannitol 
Formulation 
Weight 
variation 
            
Hardness                    
Thickness 
(mm) 
Friability 
(%) 
Disintegration time 
(sec) 
Wetting 
time (sec) 
Water 
absorption 
ratio 
Content 
uniformity Assay Q20 
(mg) (kg/cm2) (%) 
DPHMKM1 50±1.19 2 2.77±0.12 0.27±0.12 105±1.21 120±1.29 110±1.23 100.13±0.3 99.87±0.69 95.67±0.50 
DPHMKM2 52±1.12 2.5 2.59±.04 0.23±0.18 90±1.96 105±1.57 118±1.29 99.98±0.69 99.82±0.58 95.04±1.47 
DPHMKM3 50±0.99 2 2.45±0.01 0.21±0.12 40±1.23 44±1.43 121±1.30 99.80±1.23 99.74±0.46 96.38±1.28 
DPHMKG1 51±1.05 2.5 2.71±0.02 0.22±0.18 35±1.24 40±1.57 132±1.42 99.24±0.58 99.74±0.46 96.3±1.26 
DPHMKG2 50±0.89 3 2.69±0.01 0.25±0.24 28±1.52 32±1.76 135±1.46 99.85±0.86 98.69±0.97 94.83±1.64 
DPHMKG3 49±0.98 3 2.72±0.04 0.22±0.15 22±1.90 28±1.32 137±1.38 99.62±0.69 99.45±0.88 96.28±1.71 
From the above formulations modified karaya gum with glycine(DPHMKG3) has shown good DT and %release pattern. 
 
Evaluation of Orodispersible tablets of DPH using modified agar with glycine and mannitol 
Table 6: Post compression parameters of orodispersible tablets of DPH using modified agar with glycine and mannitol 
Formulation 
Weight 
variation 
Hardness 
(kg/cm2) 
Thickness 
Friability 
(%) 
Disintegration time 
(sec) 
Wetting 
time (sec) 
Water 
absorption 
ratio 
Content 
uniformity 
(%) 
Assay Q20 
DPHMAG1 50±0.98 2.5 2.71±0.02 0.28±0.21 25±1.23 30±1.12 139±1.26 99.45±0.68 99.48±0.56 95.67±0.50 
DPHMAG2 50±1.86 2.5 2.69±0.04 0.27±0.16 17±1.24 25±1.32 113±1.81 99.62±0.99 99.85±0.88 95.04±1.47 
DPHMAG3 50±0.86 3 2.72±0.02 0.27±0.16 15±1.52 23±1.76 123±1.43 99.65±0.79 99.58±0.88 96.38±1.28 
DPHMAM1 50±0.98 2 2.69±0.01 0.28±0.15 25±1.96 35±1.57 113±1.30 99±0.68 99.85±0.98 96.3±1.26 
DPHMAM2 49±1.86 2.5 2.71±0.02 0.22±0.21 20±1.90 30±1.43 118±1.29 99±0.99 98.89±0.68 94.83±1.64 
DPHMAM3 51±0.89 3 2.72±0.04 0.25±0.16 19±1.52 27±1.65 121±1.23 99±0.79 98.95±0.98 96.28±1.71 
From the above, formulations of modified agar with glycine has shown good DT and % release pattern. 
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From all the results formulations of DPHMAG2, DPHMAG3, DPHMKG2, and DPHMKG3 were selected and again formulated with spray dried lactose and compared with 
formulations of Kyron-314. 
Table 7: Evaluation of optimized formulations and comparison with formulations of Kyron-314 
 
The comparative study of optimized formulations of modified agar with glycine and 
with Kyron T-314 showed better disintegration time of 10 and 15 seconds in 
comparison to Kyron which produced 25 seconds. The wetting time and water 
absorption ratio of optimized formulations were also better than synthetic 
superdisintegrant. All the ODT parameters were found to be better than synthetic 
superdisintegrant. 
DISCUSSION 
An attempt has been made to prepare orodispersible tablets of donepezil 
hydrochloride using modified karaya gum and modified agar with glycine and 
mannitol. The prepared formulations were compared with Kyron T-314 and spray 
dried lactose as diluent for improvement in DT and other ODT parameters. The oral 
dispersible tablets formulated using modified agar with glycine (DPHMAG2, 
DPHMAG3) showed better disintegration time compared to modified karaya gum 
formulations. Different concentrations of mannitol and glycine were used in the 
formulation to study the improvement in the DT. The glycine formulations with 
modified agar gave better ODT parameters than modified karaya gum with mannitol 
and glycine formulations. The optimized formulations of modified agar with glycine 
(DPHMAG2, DPHMAG3) in different concentrations were prepared with spray dried 
lactose as diluent and compared with formulations of Kyron T-314 (DPHK3S) as 
superdisintegrant with spray dried lactose as diluent. These formulations (DPHMAG2, 
DPHMAG3) gave better ODT profiles compared to Kyron formulations (DPHK3S) 
and results of lactose and spray dried lactose as diluents in these formulations did not 
show any significant difference in ODT evaluation parameters denoting that lactose 
can be used as diluent for direct compression of this optimized formulation. To 
conclude, modified polysaccharides with glycine can be used as superdisintegrant, 
which may be a cost effective alternative in comparison to synthetic superdisintegrant 
like Kyron T-314. 
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Formulation 
Weight 
variation(mg) 
Hardness 
(kg/cm2) 
Thicknes 
(mm) 
Friability 
(%) 
Disintegration 
time (sec) 
Wetting 
time (sec) 
Water 
absorption 
ratio 
Content 
uniformity(%) 
Assay Q20 
DPHMKG2S 51±1.05 1.5 2.71±0.02 0.22±0.18 25±1.52 30±1.43 132±1.42 99.24±0.58 99.64±0. 86 97.67±0.50 
DPHMKG3S 49±0.98 2.5 2.72±0.04 0.22±0.15 20±1.98 30±1.57 137±1.38 99.62±0.69 98.75±0.88 97.38±1.28 
DPHMAG2S 50±1.86 3 2.69±0.04 0.27±0.16 15±1.24 25±1.32 113±1.81 99.62±0.99 99.98±0.79 98.97±1.64 
DPHMAG3S 50±0.86 2.5 2.72±0.02 0.27±0.16 10±1.52 15±1.76 123±1.43 99.65±0.79 99.94±0.98 99.79±1.71 
DPHK1S 50±1.19 2.5 2.77±0.12 0.27±0.12 50±1.21 62±1.21 110±1.23 101.13±0.73 99.99±0.86 94.57±0.50 
DPHK2S 52±1.12 3 2.59±.04 0.23±0.18 30±1.96 56±1.92 118±1.29 99.98±0.69 99.88±0.78 95.23±1.47 
DPHK3S 52±0.99 3 2.45±0.01 0.21±0.12 25±1.23 44±1.08 121±1.30 99.80±1.23 99.98±0.87 96.57±1.28 
